These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1505475)

  • 1. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats.
    Patchev VK; Kalogeras KT; Zelazowski P; Wilder RL; Chrousos GP
    Endocrinology; 1992 Sep; 131(3):1453-7. PubMed ID: 1505475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease.
    Zelazowski P; Patchev VK; Zelazowska EB; Chrousos GP; Gold PW; Sternberg EM
    Brain Res; 1993 Dec; 631(1):22-6. PubMed ID: 8298992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease.
    Patchev VK; Mastorakos G; Brady LS; Redwine J; Wilder RL; Chrousos GP
    Neuroendocrinology; 1993 Jul; 58(1):106-10. PubMed ID: 8264843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific up-regulation of CRH or AVP secretion by acetylcholine or lipopolysaccharide in inflammatory susceptible Lewis rat fetal hypothalamic cells.
    Wei R; Phillips TM; Sternberg EM
    J Neuroimmunol; 2002 Oct; 131(1-2):31-40. PubMed ID: 12458034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats.
    Sternberg EM; Young WS; Bernardini R; Calogero AE; Chrousos GP; Gold PW; Wilder RL
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4771-5. PubMed ID: 2786636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone.
    Calogero AE; Sternberg EM; Bagdy G; Smith C; Bernardini R; Aksentijevich S; Wilder RL; Gold PW; Chrousos GP
    Neuroendocrinology; 1992 May; 55(5):600-8. PubMed ID: 1350069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased hypothalamic [3H]flunitrazepam binding in hypothalamic-pituitary-adrenal axis hyporesponsive Lewis rats.
    Smith CC; Hauser E; Renaud NK; Leff A; Aksentijevich S; Chrousos GP; Wilder RL; Gold PW; Sternberg EM
    Brain Res; 1992 Jan; 569(2):295-9. PubMed ID: 1311618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
    Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro regulation of pituitary ACTH secretion in inflammatory disease susceptible Lewis (LEW/N) and inflammatory disease resistant Fischer (F344/N) rats.
    Zelazowski P; Smith MA; Gold PW; Chrousos GP; Wilder RL; Sternberg EM
    Neuroendocrinology; 1992 Oct; 56(4):474-82. PubMed ID: 1335552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis.
    Crofford LJ; Sano H; Karalis K; Webster EL; Goldmuntz EA; Chrousos GP; Wilder RL
    J Clin Invest; 1992 Dec; 90(6):2555-64. PubMed ID: 1281840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion.
    Kalogeras KT; Nieman LK; Friedman TC; Doppman JL; Cutler GB; Chrousos GP; Wilder RL; Gold PW; Yanovski JA
    J Clin Invest; 1996 May; 97(9):2045-50. PubMed ID: 8621793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: implications in pituitary-adrenal regulation.
    Patchev VK; Karalis K; Chrousos GP
    Brain Res; 1994 Jan; 633(1-2):312-6. PubMed ID: 7907936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.
    Calogero AE; Liapi C; Chrousos GP
    J Endocrinol Invest; 1991 Apr; 14(4):277-86. PubMed ID: 1650804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex and strain variability in the rat hypothalamo-pituitary-adrenal (HPA) axis function.
    Chisari A; Carino M; Perone M; Gaillard RC; Spinedi E
    J Endocrinol Invest; 1995 Jan; 18(1):25-33. PubMed ID: 7759781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats.
    Sternberg EM; Glowa JR; Smith MA; Calogero AE; Listwak SJ; Aksentijevich S; Chrousos GP; Wilder RL; Gold PW
    Brain Res; 1992 Jan; 570(1-2):54-60. PubMed ID: 1319794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenalectomy and experimental hypercorticalism modulate the basal, corticotropin-releasing-hormone- and arginine-vasopressin-stimulated release of hypothalamic beta-endorphin.
    Patchev VK; Racké K; Almeida OF
    Neuroendocrinology; 1991 Aug; 54(2):111-7. PubMed ID: 1766548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of repeated stressor exposure on the release of corticotropin-releasing hormone, arginine-vasopressin and bombesin-like peptides at the anterior pituitary.
    Merali Z; Hayley S; Kent P; McIntosh J; Bédard T; Anisman H
    Behav Brain Res; 2009 Mar; 198(1):105-12. PubMed ID: 19014976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S; Smith MA; Gold PW
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenylate-cyclase-dependent pituitary adrenocorticotropin secretion is defective in the inflammatory-disease-susceptible Lewis rat.
    Bernardini R; Iurato MP; Chiarenza A; Lempereur L; Calogero AE; Sternberg EM
    Neuroendocrinology; 1996 May; 63(5):468-74. PubMed ID: 8738585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.